期刊文献+

补肾填精方对再生障碍性贫血大鼠模型IL-11及EPO影响的研究 被引量:8

Experimental Study on IL-11 and EPO in Aplastic Anemia Rat Treated with Tonifying Kidney and Replenishing Essence Prescription.
原文传递
导出
摘要 目的:观察补肾填精方对再生障碍性贫血(aplastic anemia,AA)模型大鼠调控因子白细胞介素-11(interleukin-11,IL-11)及红细胞生成素(erythropoietin,EPO)的影响。方法:Wistar大鼠随机分为空白对照组、模型生理盐水组、补肾填精中药组、再障生血片组共4组各12只,对照组正常饲喂不做干预;其他3组以5-氟尿嘧啶注射液(5-FU)与马利兰合用诱发建立模型后,补肾填精中药组及再障生血片组分别给予补肾填精中药10 g·kg-1及再障生血片混悬液0.015 g·kg-1,连续4周,模型组予等量生理盐水灌胃。结果:①治疗组的白细胞(WBC)、血红蛋白(Hb)、红细胞(RBC)及血小板(PLT)较模型组均有不同程度增高,差异有统计学意义(P<0.05)。其中补肾填精中药组的WBC和PLT明显升高,差异有统计学意义(P<0.01)。②治疗组IL-11含量较模型组升高,差异有统计学意义(P<0.05)。③治疗组EPO含量较模型组降低,差异有统计学意义(P<0.05)。结论:补肾填精方能改善模型大鼠的骨髓造血功能,可改善细胞因子IL-11及EPO介导的分泌异常,促进骨髓造血功能的恢复。 Objective:To observed the effect of tonifying kidney and replenishing essence prescription(TKREP) on two regulation factors interleukin-11(IL-11) and eryhropictin(EPO) in Aplastic Anemia(AA) rats.Method: Forty eight clean grade Wistar rats were randomly divided into 4 groups,namely normal control group,AA model group,TKREP group and the aplastic blood-forming tablet(ABFT)group.The normal control group was fed with normal foods and vihicle.The other three groups were given the fluorouracil(5-FU) plus Myleran to induce AA model of rat.After that,the TKREP group and ABFT group rats were fed with TKREP(10 g·kg-1·d-1)and ABFT(0.015 g·kg-1·d-1) for 4 weeks.While,the AA model group was fed 0.9% NaCl.Result:①Compared to model group,the numbers of red blood cells and hemoglobin in treatment group were decreased,the difference was statistically significant(P0.05);the numbers of white blood cells and platelet in TKREP group were significantly decreased,the difference was statistically significant(P0.01);②EPO levels were elevated in treatment group,the difference was statistically significant(P0.05);③while the IL-11 level was increased slightly,the difference was statistically significant(P0.05).Conclusion: From point view of tonifying kidney,the TKREP could significantly improve bone marrow hematopoietic function against 5-FU plus Myleran,to a certain extent,effectively improve abnormal secreteing of regulation factors(IL-11 and EPO) and encouraged the bone marrow hematopoietic function's recover.
出处 《中国实验方剂学杂志》 CAS 北大核心 2012年第8期225-227,共3页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 再生障碍性贫血 补肾填精 白细胞介素-11 红细胞生成素 anemia aplastic tonifying kidney and vreplenishing essence IL-11 EPO
  • 相关文献

参考文献5

二级参考文献5

  • 1赵堂富,中华血液学杂志,1988年,9卷,80页
  • 2赵堂富,中华血液学杂志,1987年,8卷,249页
  • 3Judit Demeter,Gerald Messer,Hubert Schrezenmeier. Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia[J] 2002,Annals of Hematology(10):566~569
  • 4S. I. Kapustin,T. I. Popova,A. A. Lyshchov,E. N. Imyanitov,M. N. Blinov,K. M. Abdulkadyrov. HLA-DR4-Ala74β is associated with risk and poor outcome of severe aplastic anemia[J] 2001,Annals of Hematology(2):66~71
  • 5申蓉,徐从高,李丽珍,张锑,秦雪梅,李杰,赵川莉.再生障碍性贫血患者T淋巴细胞早期激活及可溶性肿瘤坏死因子受体的研究[J].中华血液学杂志,2004,25(4):209-212. 被引量:23

共引文献96

同被引文献172

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部